{"id":984377,"date":"2026-07-23T19:19:25","date_gmt":"2026-07-23T23:19:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/"},"modified":"2026-07-23T19:19:25","modified_gmt":"2026-07-23T23:19:25","slug":"immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/","title":{"rendered":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026"},"content":{"rendered":"
\n

DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) — Immunovant, Inc.\u00a0(Nasdaq:\u00a0IMVT<\/strong>) today announced that it will report its financial results for the first quarter ended June 30, 2026 on Thursday, August 6, 2026 before the market opens. Roivant Sciences Ltd. (ROIV), Immunovant\u2019s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that same day, which will include a business update for Immunovant.<\/p>\n

To access the\u00a0Roivant (Nasdaq: ROIV)\u00a0conference call by phone, please register online using this registration link<\/u><\/a>.<\/u> The presentation and webcast details will also be available under \u201cNews & Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar<\/u><\/a>. The archived webcast will be available on Immunovant\u2019s website after the conference call.<\/p>\n

\n About\u00a0Immunovant<\/strong>\u00a0<\/p>\n

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit\u00a0immunovant.com<\/a>.\u00a0<\/p>\n

\n Contacts:<\/strong>\u00a0<\/p>\n

\n Investors<\/u>\u00a0<\/p>\n

Keyur Parekh\u00a0<\/p>\n

keyur.parekh@roivant.com\u00a0\u00a0<\/p>\n

\n Media<\/u>\u00a0<\/p>\n

Stephanie Lee\u00a0<\/p>\n

stephanie.lee@roivant.com\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) — Immunovant, Inc.\u00a0(Nasdaq:\u00a0IMVT) today announced that it will report its financial results for the first quarter ended June 30, 2026 on Thursday, August 6, 2026 before the market opens. Roivant Sciences Ltd. (ROIV), Immunovant\u2019s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that same day, which will include a business update for Immunovant. To access the\u00a0Roivant (Nasdaq: ROIV)\u00a0conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under \u201cNews & Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar. The archived webcast will be available on Immunovant\u2019s website after the conference call. About\u00a0Immunovant\u00a0 Immunovant, Inc. … <\/p>\n

Continue reading “Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-984377","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nImmunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) — Immunovant, Inc.\u00a0(Nasdaq:\u00a0IMVT) today announced that it will report its financial results for the first quarter ended June 30, 2026 on Thursday, August 6, 2026 before the market opens. Roivant Sciences Ltd. (ROIV), Immunovant\u2019s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that same day, which will include a business update for Immunovant. To access the\u00a0Roivant (Nasdaq: ROIV)\u00a0conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under \u201cNews & Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar. The archived webcast will be available on Immunovant\u2019s website after the conference call. About\u00a0Immunovant\u00a0 Immunovant, Inc. … Continue reading "Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-23T23:19:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026\",\"datePublished\":\"2026-07-23T23:19:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/\"},\"wordCount\":220,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/\",\"name\":\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ=\",\"datePublished\":\"2026-07-23T23:19:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/","og_locale":"en_US","og_type":"article","og_title":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026 - Market Newsdesk","og_description":"DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) — Immunovant, Inc.\u00a0(Nasdaq:\u00a0IMVT) today announced that it will report its financial results for the first quarter ended June 30, 2026 on Thursday, August 6, 2026 before the market opens. Roivant Sciences Ltd. (ROIV), Immunovant\u2019s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that same day, which will include a business update for Immunovant. To access the\u00a0Roivant (Nasdaq: ROIV)\u00a0conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under \u201cNews & Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar. The archived webcast will be available on Immunovant\u2019s website after the conference call. About\u00a0Immunovant\u00a0 Immunovant, Inc. … Continue reading \"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-23T23:19:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026","datePublished":"2026-07-23T23:19:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/"},"wordCount":220,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/","name":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ=","datePublished":"2026-07-23T23:19:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2NzM3MyM3NzIxMDI5IzIxMjU4NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-first-quarter-ended-june-30-2026-and-provide-business-update-on-thursday-august-6-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0First\u00a0Quarter Ended\u00a0June\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Thursday,\u00a0August\u00a06, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/984377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=984377"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/984377\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=984377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=984377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=984377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}